4/13/2010

Mylan gained FDA approval to market generic formulations of Merck & Co.'s blood pressure drug Hyzaar and GlaxoSmithKline's antidepressant Wellbutrin SR. The generic-drug firm has started shipping the products, known as losartan potassium and hydrochlorothiazide tablets and bupropion hydrochloride extended-release tablets, respectively.

Related Summaries